Literature DB >> 20546788

Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006.

Thomas Munk Laursen1, Merete Nordentoft.   

Abstract

Persons with schizophrenia and bipolar disorder have much higher heart disease mortality rates than the general population. The objective was to compare the general population with persons with schizophrenia, bipolar disorder or other psychiatric disorders in terms of rates of somatic hospitalization and invasive heart disease procedures, and in terms of heart disease mortality during the period 1994 to 2006. Survival analysis was used to analyze heart disease mortality and somatic care trends in a cohort of all persons residing in Denmark. During the study period, heart disease mortality rose significantly among persons with schizophrenia: compared with the general population, the rise in the mortality rate ratio equalled 1.12 (95% confidence interval (CI) 1.08-1.15) every second year. This was not the case for persons with bipolar disorder [1.02 (0.98-1.05), not significant] or other psychiatric disorders [1.00 (0.99-1.01), not significant]. The entire period saw a lower hospitalization rate and fewer invasive cardiac procedures among persons with schizophrenia than among the general population. The higher mortality (with increasing trends) from heart disease in persons with schizophrenia compared to the rest of the cohort members can be explained partly by low rates of invasive cardiac procedures. However, other reasons, such as antipsychotic-induced weight gain, primary prevention, and difficulty following smoking cessation advice could also be part of the explanation. The results call for a greater focus on improvement in somatic care and lifestyle factors for this group of patients. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20546788     DOI: 10.1016/j.jpsychires.2010.04.027

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  26 in total

Review 1.  Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis.

Authors:  M L Prieto; A B Cuéllar-Barboza; W V Bobo; V L Roger; F Bellivier; M Leboyer; C P West; M A Frye
Journal:  Acta Psychiatr Scand       Date:  2014-05-22       Impact factor: 6.392

2.  A widening longevity gap between people with schizophrenia and general population: A literature review and call for action.

Authors:  Ellen E Lee; Jinyuan Liu; Xin Tu; Barton W Palmer; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2017-09-28       Impact factor: 4.939

3.  Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia.

Authors:  Nancy E Morden; Zongshan Lai; David E Goodrich; Todd MacKenzie; John F McCarthy; Karen Austin; Deborah E Welsh; Stephen Bartels; Amy M Kilbourne
Journal:  Gen Hosp Psychiatry       Date:  2012-04-18       Impact factor: 3.238

4.  The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity.

Authors:  Helene Speyer; Hans Christian Brix Nørgaard; Merete Birk; Mette Karlsen; Ane Storch Jakobsen; Kamilla Pedersen; Carsten Hjorthøj; Charlotta Pisinger; Christian Gluud; Ole Mors; Jesper Krogh; Merete Nordentoft
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

5.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.

Authors:  Wing Chung Chang; Joe Kwun Nam Chan; Corine Sau Man Wong; JoJo Siu Han Hai; Philip Chi Fai Or; Eric Yu Hai Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

6.  Genetic investigations of 100 inherited cardiac disease-related genes in deceased individuals with schizophrenia.

Authors:  Sofie Lindgren Christiansen; Jeppe Dyrberg Andersen; Gonçalo Espregueira Themudo; Christin Løth Hertz; Johannes Rødbro Busch; Martin Roest Christensen; Kristine Boisen Olsen; Jytte Banner; Niels Morling
Journal:  Int J Legal Med       Date:  2021-05-11       Impact factor: 2.686

7.  Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries.

Authors:  Thomas Munk Laursen; Kristian Wahlbeck; Jonas Hällgren; Jeanette Westman; Urban Ösby; Hassan Alinaghizadeh; Mika Gissler; Merete Nordentoft
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

9.  Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden.

Authors:  Jeanette Westman; Jonas Hällgren; Kristian Wahlbeck; David Erlinge; Lars Alfredsson; Urban Osby
Journal:  BMJ Open       Date:  2013-04-18       Impact factor: 2.692

10.  Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden.

Authors:  Merete Nordentoft; Kristian Wahlbeck; Jonas Hällgren; Jeanette Westman; Urban Osby; Hassan Alinaghizadeh; Mika Gissler; Thomas Munk Laursen
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.